Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Australasian Leukaemia and Lymphoma Group
British Columbia Cancer Agency
Merck Sharp & Dohme LLC
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center